CATALIO CAPITAL MANAGEMENT, LP
Latest 13F filing data - Q1 2026
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | GUTS | 5.49M | $2.51M |
 | ELDN | 1.64M | $5.05M |
 | HYPR | 1.32M | $1.43M |
 | SNDX | 1.04M | $24.38M |
 | DFTX | 1.04M | $19.62M |
 | KPTI | 898K | $5.00M |
 | CRVS | 892K | $13.05M |
 | RARE | 851K | $17.82M |
 | ADPT | 723K | $10.03M |
 | TARA | 580K | $3.02M |
 | DNTH | 560K | $47.02M |
 | MGX | 529K | $708.85K |
 | QURE | 491K | $8.03M |
 | MLYS | 439K | $11.89M |
 | BBIO | 432K | $32.08M |
KALVISTA PHARMACEUTICALS INC | KALV | 427K | $8.59M |
 | BMY | 421K | $25.52M |
 | HTFL | 404K | $9.82M |
 | BSX | 299K | $18.78M |
 | SEPN | 294K | $7.07M |
Fractyl Health, Inc.
GUTS
Shares Held
5.49M
Value
$2.51M
Eledon Pharmaceuticals, Inc.
ELDN
Shares Held
1.64M
Value
$5.05M
Hyperfine, Inc.
HYPR
Shares Held
1.32M
Value
$1.43M
Syndax Pharmaceuticals, Inc.
SNDX
Shares Held
1.04M
Value
$24.38M
Definium Therapeutics, Inc.
DFTX
Shares Held
1.04M
Value
$19.62M
Karyopharm Therapeutics Inc.
KPTI
Shares Held
898K
Value
$5.00M
Corvus Pharmaceuticals, Inc.
CRVS
Shares Held
892K
Value
$13.05M
Ultragenyx Pharmaceutical Inc.
RARE
Shares Held
851K
Value
$17.82M
Adaptive Biotechnologies Corporation
ADPT
Shares Held
723K
Value
$10.03M
Protara Therapeutics, Inc.
TARA
Shares Held
580K
Value
$3.02M
Dianthus Therapeutics, Inc.
DNTH
Shares Held
560K
Value
$47.02M
Metagenomi, Inc. Common Stock
MGX
Shares Held
529K
Value
$708.85K
uniQure N.V.
QURE
Shares Held
491K
Value
$8.03M
Mineralys Therapeutics, Inc.
MLYS
Shares Held
439K
Value
$11.89M
BridgeBio Pharma, Inc.
BBIO
Shares Held
432K
Value
$32.08M
KALVISTA PHARMACEUTICALS INC
KALV
Shares Held
427K
Value
$8.59M
Bristol-Myers Squibb Company
BMY
Shares Held
421K
Value
$25.52M
Heartflow, Inc. Common Stock
HTFL
Shares Held
404K
Value
$9.82M
Boston Scientific Corporation
BSX
Shares Held
299K
Value
$18.78M
Septerna Inc
SEPN
Shares Held
294K
Value
$7.07M